HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$16.24
Day range
$16.04 - $17.68
Year range
$6.07 - $19.71
Market cap
958.27M USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 7.32M | — |
Operating expense | 83.25M | 162.60% |
Net income | -91.45M | -123.23% |
Net profit margin | -1.25K | — |
Earnings per share | -1.25 | -48.81% |
EBITDA | -77.10M | -144.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 276.24M | 11.01% |
Total assets | 319.38M | 20.50% |
Total liabilities | 553.20M | 123.57% |
Total equity | -233.83M | — |
Shares outstanding | 59.59M | — |
Price to book | -4.07 | — |
Return on assets | -57.18% | — |
Return on capital | -65.17% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -91.45M | -123.23% |
Cash from operations | -70.72M | -218.56% |
Cash from investing | -46.00K | -666.67% |
Cash from financing | 24.77M | -82.49% |
Net change in cash | -46.00M | -138.56% |
Free cash flow | -52.76M | -429.69% |
About
Founded
2018
Headquarters
Website
Employees
452